Briacell Cash And Short Term Investments vs Total Current Assets Analysis

BCTX Stock  USD 0.53  0.03  5.54%   
Briacell Therapeutics financial indicator trend analysis is way more than just evaluating Briacell Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Briacell Therapeutics is a good investment. Please check the relationship between Briacell Therapeutics Cash And Short Term Investments and its Total Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Briacell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Cash And Short Term Investments vs Total Current Assets

Cash And Short Term Investments vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Briacell Therapeutics Cash And Short Term Investments account and Total Current Assets. At this time, the significance of the direction appears to have totally related.
The correlation between Briacell Therapeutics' Cash And Short Term Investments and Total Current Assets is 1.0. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Briacell Therapeutics Corp, assuming nothing else is changed. The correlation between historical values of Briacell Therapeutics' Cash And Short Term Investments and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Briacell Therapeutics Corp are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Cash And Short Term Investments i.e., Briacell Therapeutics' Cash And Short Term Investments and Total Current Assets go up and down completely randomly.

Correlation Coefficient

1.0
Relationship DirectionPositive 
Relationship StrengthVery Strong

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Briacell Therapeutics balance sheet. This account contains Briacell Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Briacell Therapeutics Corp fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Briacell Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Briacell Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Briacell Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Briacell Therapeutics' Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 77 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 4.2 M in 2024.

Briacell Therapeutics fundamental ratios Correlations

-0.10.79-0.98-0.33-0.050.98-0.04-0.10.980.450.540.720.520.980.02-0.08-0.050.090.35-0.05-0.450.420.84-0.440.79
-0.1-0.290.17-0.750.92-0.18-0.080.93-0.190.68-0.07-0.020.12-0.140.90.19-0.23-0.930.22-0.23-0.510.410.06-0.53-0.24
0.79-0.29-0.80.18-0.220.80.09-0.210.8-0.07-0.060.91-0.10.77-0.26-0.140.110.22-0.140.11-0.160.170.89-0.130.98
-0.980.17-0.80.240.15-1.00.190.19-1.0-0.37-0.52-0.69-0.49-1.00.090.030.18-0.18-0.30.180.41-0.43-0.840.42-0.83
-0.33-0.750.180.24-0.76-0.240.13-0.7-0.23-0.98-0.56-0.03-0.7-0.3-0.860.010.260.72-0.670.260.62-0.52-0.230.650.13
-0.050.92-0.220.15-0.76-0.160.050.99-0.160.72-0.070.050.1-0.110.96-0.19-0.1-0.990.18-0.09-0.360.210.13-0.36-0.19
0.98-0.180.8-1.0-0.24-0.16-0.19-0.191.00.360.520.690.491.0-0.1-0.03-0.180.180.3-0.18-0.40.440.84-0.430.83
-0.04-0.080.090.190.130.05-0.190.04-0.19-0.13-0.170.2-0.19-0.20.01-0.240.98-0.03-0.20.990.09-0.33-0.130.32-0.12
-0.10.93-0.210.19-0.70.99-0.190.04-0.20.66-0.150.030.02-0.160.93-0.18-0.11-0.990.09-0.11-0.310.240.12-0.38-0.18
0.98-0.190.8-1.0-0.23-0.161.0-0.19-0.20.350.520.690.491.0-0.11-0.04-0.180.190.29-0.18-0.390.430.84-0.420.83
0.450.68-0.07-0.37-0.980.720.36-0.130.660.350.620.090.740.420.81-0.1-0.24-0.670.62-0.24-0.580.490.31-0.63-0.02
0.54-0.07-0.06-0.52-0.56-0.070.52-0.17-0.150.520.62-0.10.980.560.110.02-0.160.130.71-0.17-0.340.340.09-0.37-0.03
0.72-0.020.91-0.69-0.030.050.690.20.030.690.09-0.1-0.090.680.03-0.080.18-0.050.080.18-0.370.150.89-0.160.87
0.520.12-0.1-0.49-0.70.10.49-0.190.020.490.740.98-0.090.540.270.08-0.22-0.040.76-0.22-0.450.420.1-0.48-0.07
0.98-0.140.77-1.0-0.3-0.111.0-0.2-0.161.00.420.560.680.54-0.04-0.03-0.190.150.37-0.19-0.430.450.84-0.450.8
0.020.9-0.260.09-0.860.96-0.10.010.93-0.110.810.110.030.27-0.04-0.16-0.13-0.930.41-0.13-0.410.290.15-0.45-0.23
-0.080.19-0.140.030.01-0.19-0.03-0.24-0.18-0.04-0.10.02-0.080.08-0.03-0.16-0.230.140.13-0.23-0.490.28-0.17-0.27-0.11
-0.05-0.230.110.180.26-0.1-0.180.98-0.11-0.18-0.24-0.160.18-0.22-0.19-0.13-0.230.13-0.231.00.17-0.41-0.160.41-0.1
0.09-0.930.22-0.180.72-0.990.18-0.03-0.990.19-0.670.13-0.05-0.040.15-0.930.140.13-0.130.120.36-0.22-0.120.360.19
0.350.22-0.14-0.3-0.670.180.3-0.20.090.290.620.710.080.760.370.410.13-0.23-0.13-0.23-0.490.280.15-0.35-0.1
-0.05-0.230.110.180.26-0.09-0.180.99-0.11-0.18-0.24-0.170.18-0.22-0.19-0.13-0.231.00.12-0.230.17-0.41-0.160.41-0.1
-0.45-0.51-0.160.410.62-0.36-0.40.09-0.31-0.39-0.58-0.34-0.37-0.45-0.43-0.41-0.490.170.36-0.490.17-0.52-0.360.6-0.18
0.420.410.17-0.43-0.520.210.44-0.330.240.430.490.340.150.420.450.290.28-0.41-0.220.28-0.41-0.520.37-0.980.26
0.840.060.89-0.84-0.230.130.84-0.130.120.840.310.090.890.10.840.15-0.17-0.16-0.120.15-0.16-0.360.37-0.380.92
-0.44-0.53-0.130.420.65-0.36-0.430.32-0.38-0.42-0.63-0.37-0.16-0.48-0.45-0.45-0.270.410.36-0.350.410.6-0.98-0.38-0.21
0.79-0.240.98-0.830.13-0.190.83-0.12-0.180.83-0.02-0.030.87-0.070.8-0.23-0.11-0.10.19-0.1-0.1-0.180.260.92-0.21
Click cells to compare fundamentals

Briacell Therapeutics Account Relationship Matchups

Briacell Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets478.3K58.0M42.6M27.2M5.9M10.3M
Total Current Liabilities3.6M556.8K941.1K1.8M7.5M7.8M
Total Stockholder Equity(3.3M)57.3M10.3M(3.8M)(2.4M)(2.3M)
Net Debt209.3K(57.2M)(41.0M)(21.3M)(862.1K)(905.2K)
Retained Earnings(16.6M)(15.8M)(60.3M)(80.7M)(85.4M)(81.2M)
Accounts Payable4.2K214.1K463.3K1.1M7.2M7.5M
Cash19.5K57.3M41.0M21.3M862.1K819.0K
Non Current Assets Total238.9K245.6K230.3K215.1K2.2M1.2M
Cash And Short Term Investments19.5K57.3M41.0M21.3M862.1K819.0K
Common Stock Shares Outstanding713.9K4.5M15.5M15.6M16.5M17.3M
Liabilities And Stockholders Equity478.3K58.0M42.6M27.2M5.9M10.3M
Non Current Liabilities Total142.8K225.4K31.3M29.1M1.1M1.0M
Other Stockholder Equity2.2M39.0M5.2M7.4M11.0M8.1M
Total Liab3.8M782.2K32.2M30.9M8.6M4.8M
Total Current Assets239.4K57.8M42.3M26.9M3.7M3.5M
Net Receivables20.6K12.6K24.1K717.7K1.4M1.4M
Other Current Liab3.4M480.7K741.8K677.7K290.4K275.9K
Inventory(305.0)1.0(24.1K)(18.9K)(1.4M)(1.3M)
Other Current Assets199.7K516.9K1.3M5.0M1.4M721.5K
Accumulated Other Comprehensive Income(81.0K)(94.5K)(127.0K)(138.7K)(124.8K)(118.6K)
Intangible Assets238.9K245.6K230.3K215.1K199.8K182.9K
Net Tangible Assets(1.2M)(4.7M)57.0M10.1M11.6M11.5M
Net Invested Capital(4.1M)57.3M10.3M(3.8M)(2.4M)(2.3M)
Net Working Capital(4.5M)57.2M41.4M25.1M(3.8M)(3.6M)
Common Stock11.2M54.8M65.6M69.6M72.2M41.0M
Capital Stock11.2M54.8M65.6M69.6M72.2M45.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Briacell Stock Analysis

When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.